Nomura on Sun Pharma
Buy, TP Rs 525
Remain positive on Specialty sales ramp up, but
take conservative stance on Generics
Currently trading at 20.5x Nov 2020F EPS of Rs 22.1. Think valuation multiple could increase with visibility on specialty ramp-up